Skip to main content
. 2020 Oct 22;11:574357. doi: 10.3389/fpsyt.2020.574357

Table 2.

Group results follow-up measurements and EMA–trial.

ESM-trial (n = 19) RCT Stop (n = 8) RCT Go (n = 4) Cohort (n = 7)
No. of recurrences 1 0 1
Mean number of responses (SD) 40.9 (34.4) 19.2 (13.9) 48.9 (27.4)
Positive affect
   B 0.07 (0.31) 0.25 (0.44) −0.04 (0.12)
   R2 0.09 (0.13) 0.19 (0.12) 0.03 (0.05)
Negative affect
   B 1.06 (3.15) −0.25 (0.49) 0.10 (0.20)
   R2 0.21 (0.26) 0.11 (0.18) 0.09 (0.13)
Stress 31.79 (14.16) 23.35 (11.65) 25.52 (31.82)
Main trial results (n = 121) RCT Stop (n = 19) RCT Go (n = 19) Cohort (n = 83)
Mean birthweight, in gram (SD) 3,632.1 (474.3) 3,369 (422.9) 3,382.6 (463.2)
Mean gestational age, in days (SD) 277 (6.9) 275 (5.5) 275 (9.3)
Mean BW for GA, percentile (SD) 43.4 (33.7) 41.6 (31.2) 48.2 (29.8)

Numbers are rounded. RCT, Randomized controlled trial; RCT Stop, RCT group receiving preventive cognitive therapy while tapering ADM; RCT Go, RCT group continuing ADM; ADM, antidepressant medication; ESM, experience sampling methodology; BW, birthweight; GA, gestational age; Mean BW for GA, birthweight corrected for gestational age.